Cardiol Therarpeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial
CBD September 25, 2020
Ryan Allway September 25th, 2020 News, Top News Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD) Oakville, Ontario–(Newsfile Corp. – September 25, 2020) – Cardiol... Read more
CFN Media Exclusive Update from FluroTech President and CEO
November 4, 2019
Rachelle Gordon November 4th, 2019 App, Exclusive, News, Top Story In the burgeoning cannabis industry, testing companies are often considered the gatekeepers to success. Between consumer demand and regulatory obligations, marijuana producers are compelled to provide a full analysis of what they’re putting on the market and accurate results... Read more
New Report: Women Prefer Cannabis Strains High in CBD
CBD October 30, 2019
Ryan Allway October 30th, 2019 RYAH Finds Top Priority is Treating Mental Health, Over 28,000 Women Surveyed New York, NY, October 30, 2019 – RYAH Medtech, Inc. (“RYAH” or the “Company”), a big data and technology company focused on valuable predictive analysis in the global medical plant intake industry,... Read more
Ash Stringer September 29th, 2019 App, Exclusive, News, Top Story If a company wants to generate substantial revenue from a tobacco product, it better get into convenience stores. According to the National Association of Convenience Stores (NACS) 2019 State of the Industry Report, conventional cigarette sales are declining, but... Read more
Plus Products Advances Strategic Plan with Rebranding, CBD Line Supported by John Legend and Casper Sleep
September 29, 2019
Tony Deyes September 29th, 2019 App, Exclusive, Top News Some cannabis companies choose to employ a shotgun approach to building their brands, launching a wide variety of products in the hopes that some are successful. The team at Plus Products (CSE: PLUS, OTCQB: PLPRF) has taken a more focused... Read more
Ash Stringer September 9th, 2019 App, Exclusive, News, Top Story The negative stigmas attached to cannabis continue to fade away like a puff of smoke in the wind. Most people are now well aware of the therapeutic benefits of the cannabis plant and its cousin hemp. Investors are certainly... Read more
Robin Lefferts August 26th, 2019 App, Exclusive, News, Top Story Cannabidiol, or CBD, is the main non-psychotropic active ingredient in cannabis and hemp. In the United States, passage of the 2018 Farm Bill led the federal government to declassify hemp as a dangerous drug, opening the doors for states... Read more
